HCW Biologics director Gary M. Winer resigns after failing to be re-elected at 2025 annual meeting

HCW Biologics Inc.

Gary M. Winer resigned from board effective June 17, 2025; seat will remain vacant.
Shareholder vote: Scott T. Garrett elected with 534,541 for; Winer had 133,365 for and 410,361 withheld.
Stockholders ratified Crowe LLP as auditor for FY 2025 (693,874 for, 595 against).
Broadridge technical glitch prevented some stockholders from virtual meeting; a quorum was present and meeting validly held.
Replay of annual meeting available at www.virtualshareholdermeeting.com/HCWB2025 through July 31, 2025.

item 5.02 item 5.07 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gary M. Winer

Director

HCWB · HCW Biologics Inc.

Effective: 2025-06-17
Filed: June 23, 2025, 7:59 PM ET

On June 17, 2025, after the Annual Meeting, HCW Biologics Inc. accepted Gary M. Winer’s resignation from the Company’s Board of Directors, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gary M. Winer resigned as Director at HCW Biologics Inc..

Action: resigned
Role: Director

Exact text from the filing

On June 17, 2025, after the Annual Meeting, HCW Biologics Inc. accepted Gary M. Winer’s resignation from the Company’s Board of Directors, effective immediately.

View on SEC.gov

HCW Biologics Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-089035

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.